Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors

Abstract

The activation of caspase-3 represents a critical step in the pathways leading to the biochemical and morphological changes that underlie apoptosis. Upon induction of apoptosis, the large (p17) and small (p12) subunits, comprising active caspase-3, are generated via proteolytic processing of a latent proenzyme dimer. Two copies of each individual subunit are generated to form an active heterotetramer. The tetrameric form of caspase-3 cleaves specific protein substrates within the cell, thereby producing the apoptotic phenotype. In contrast to the proenzyme, once activated in HeLa cells, caspase-3 is difficult to detect due to its rapid degradation. Interestingly, however, enzyme stability and therefore detection of active caspase-3 by immunoblot analysis can be restored by treatment of cells with a peptide-based caspase-3 selective inhibitor, suggesting that the active form can be stabilized through protein-inhibitor interaction. The heteromeric active enzyme complex is necessary for its stabilization by inhibitors, as expression of the large subunit alone is not stabilized by the presence of inhibitors. Our results show for the first time, that synthetic caspase inhibitors not only block caspase activity, but may also increase the stability of otherwise rapidly degraded mature caspase complexes. Consistent with these findings, experiments with a catalytically inactive mutant of caspase-3 show that rapid turnover is dependent on the activity of the mature enzyme. Furthermore, turnover of otherwise stable active site mutants of capase-3 is rescued by the presence of the active enzyme suggesting that turnover can be mediated in trans.

Eupatilin induces human renal cancer cell apoptosis via ROS-mediated MAPK and PI3K/AKT signaling pathways

“…Apoptosis has been recognized as one of the most important biological features of RCC progression, and the execution of apoptosis requires the accurate coordination of the caspase protein family (20). Caspase-3, also known as the death enzyme, plays a critical role in the controlled execution of programmed cell death (21). The results of the present study reveal that eupatilin significantly inhibited RCC cell proliferation, and induced RCC apoptosis, as well as the activity of caspase-3.…”

Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549

“…As a central apoptotic effector, it plays a key role in promoting apoptosis [14] . After cleaving caspase-3, the active form of caspase 3 is released, indicating that the caspase 3 proenzyme is activated and has begun to execute its apoptotic function [15] .…”

Ebola Virus Does Not Block Apoptotic Signaling Pathways

“…7A). As cleaved caspases are rapidly degraded, Western blot quantification is not a suitable tool to quantify caspase cleavage and was therefore not performed (44,45).…”